| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
BASIC SCIENCE |
Department of Medicine, Division of Nephrology, University of Texas Health Science Center, San Antonio; and South Texas Veterans Health Care System, Audie Murphy Division, San Antonio, Texas.
Correspondence to Dr. Jennifer L. Gooch, Medicine/Nephrology, University of Texas Health Science Center, San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229-3900. Phone: 210-567-4700; Fax: 210-567-4412; E-mail: Gooch{at}uthscsa.edu
ABSTRACT. Calcineurin is an important signaling molecule in mesangial cells in vitro and is involved in some manifestations of diabetic nephropathy in vivo. However, calcineurin acts in a cell-specific and tissue-specific manner in the kidney, and mechanisms of specificity are unknown. Three closely related isoforms of the calcineurin A (CnA) subunit are expressed in a tissue-specific manner. This study was undertaken to determine if specificity of calcineurin action is linked to regulation of CnA isoforms in the diabetic kidney. After induction of diabetes with streptozotocin, expression of all three CnA isoforms rapidly increased, primarily in the thick ascending limb of Henle (TAL). After prolonged diabetes, increase specifically of the
isoform was observed in collecting ducts (CD) and in endothelial cells of glomeruli. Aquaporin 2 (AQP2), a putative substrate of calcineurin phosphatase in the kidney, is also involved in diabetic nephropathy. Co-localization of CnA isoforms with AQP2 revealed that CnA-
is the predominant isoform that associates with AQP2 in the diabetic kidney. Furthermore, inhibition of calcineurin with cyclosporin A (CsA) alters AQP2 localization and phosphorylation in principal cells of CD. Alterations in subcellular localization of AQP2 were parallel with CnA-
. Similarly, CsA treatment results in a further increase in urine output compared with diabetes alone, suggesting a functional consequence of inhibiting calcineurin-mediated regulation of AQP2. In conclusion, all three isoforms of CnA are upregulated in the diabetic kidney. Increased expression of CnA-
, in particular, is observed in glomeruli and CD and participates in regulation of AQP2 expression, phosphorylation, and function.
This article has been cited by other articles:
![]() |
R. A. Fenton and M. A. Knepper Mouse Models and the Urinary Concentrating Mechanism in the New Millennium Physiol Rev, October 1, 2007; 87(4): 1083 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Aird Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds Circ. Res., February 2, 2007; 100(2): 174 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Gooch, R. L. Guler, J. L. Barnes, and J. J. Toro Loss of calcineurin A{alpha} results in altered trafficking of AQP2 and in nephrogenic diabetes insipidus J. Cell Sci., June 15, 2006; 119(12): 2468 - 2476. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oka, Y.-S. Dai, and J. D. Molkentin Regulation of Calcineurin through Transcriptional Induction of the calcineurin A{beta} Promoter In Vitro and In Vivo Mol. Cell. Biol., August 1, 2005; 25(15): 6649 - 6659. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Moz, R. Levi, V. Lavi-Moshayoff, K. B. Cox, J. D. Molkentin, J. Silver, and T. Naveh-Many Calcineurin A{beta} Is Central to the Expression of the Renal Type II Na/Pi Co-transporter Gene and to the Regulation of Renal Phosphate Transport J. Am. Soc. Nephrol., December 1, 2004; 15(12): 2972 - 2980. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Gooch, J. J. Toro, R. L. Guler, and J. L. Barnes Calcineurin A-{alpha} But Not A-{beta} Is Required for Normal Kidney Development and Function Am. J. Pathol., November 1, 2004; 165(5): 1755 - 1765. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673